and (extended or continuous or short or intermittent or bolus or prolonged or discontinuous) and (infusion). The bibliographies of all relevant articles were also hand-searched in order to ...
The FDA approved a one-time, five-minute IV bolus infusion of tenecteplase for adults with acute ischemic stroke. Image: Adobe Stock "The approval of TNKase represents a meaningful advancement in ...
Patients were then randomized to receive an intravenous infusion of either 15 µg/kg salbutamol ... Conclusion: A single-dose intravenous salbutamol bolus of 15 µg/kg administered over 10 mins ...
IV: CT of head or body: 75–150mL or 100–150mL bolus infusion; max 150mL. Excretory urography (normal renal function): 1mL/kg; max 100mL. CCTA (bolus inj with test bolus or bolus tracking): 50 ...
TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.
compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback